Daniel An

MedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer”.

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer

Science Translational Medicine(2023)10.1126/scitranslmed.add7872

N/A

0.790DataRank · unranked

25 citations

Tzu‐Ting Huang, Jayakumar R. Nair, Daniel An, Grant Zurcher, Erika J. Lampert +12 more

Prexasertib, a cell cycle checkpoint kinase 1 inhibitor, in BRCA mutant recurrent high-grade serous ovarian cancer (HGSOC): A proof-of-concept single arm phase II study.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6038

N/A

0.312DataRank · unranked

7 citations

Daniel An, Ann McCoy, Elise C. Kohn, Christina M. Annunziata, Kathryn Trewhitt +4 more

The UTHealth Houston Adult Cardiovascular Genomics Certificate Program: Efficacy and Impact on Healthcare Professionals

Research Square(2024)10.21203/rs.3.rs-4469272/v1

N/A

0.104DataRank · unranked

1 citations

B. Rajani, Priyanka K. Vaidya, Samer Abu Dayeh, Alana C. Cecchi, Christina C. Miyake +15 more

Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatment

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.07.031

N/A

0DataRank · unranked

31 citations

Christina M. Annunziata, John L. Hays, Liang Cao, Peter L. Choyke, Minshu Yu +8 more

579-D Multiplex imaging of ovarian carcinoma reveals spatial cell interaction patterns predictive of immunotherapy responses

DOAJ (DOAJ: Directory of Open Access Journals)(2023)10.1136/jitc-2023-sitc2023.0579-d

N/A

0DataRank · unranked

0 citations

Jung‐Min Lee, Elena Giudice, Edward C. Schrom, Andrea J. Radtke, Nitasha Gupta +4 more

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA-mutant ovarian cancer

medRxiv(2022)10.1101/2022.12.02.22283037

N/A

0DataRank · unranked

2 citations

Tzu‐Ting Huang, Jayakumar R. Nair, Daniel An, Grant Zurcher, Erika J. Lampert +12 more

Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000516

N/A

0DataRank · unranked

27 citations

Ashley Cimino‐Mathews, Joo Sang Lee, Jayakumar R. Nair, Min-Jung Lee, Akira Yuno +5 more

Recent advancements of antiangiogenic combination therapies in ovarian cancer

Cancer Treatment Reviews(2021)10.1016/j.ctrv.2021.102224

N/A

0DataRank · unranked

80 citations

Susana Banerjee, Jungmin Lee, Daniel An